BLUE SAIL MEDICAL(SZ:002382) Sou Hu Cai Jing·2025-12-03 13:33Core Viewpoint - Bluefan Medical (002382) has experienced a decline in stock price and financial performance, indicating potential challenges in the medical device industry [1][3]. Financial Performance - As of December 3, 2025, Bluefan Medical's stock closed at 5.6 yuan, down 0.71% with a trading volume of 69,300 shares and a turnover of 38.97 million yuan [1]. - The company reported a total revenue of 4.182 billion yuan for the first three quarters of 2025, a year-on-year decrease of 10.15% [3]. - The net profit attributable to shareholders was -286 million yuan, a decline of 30.09% year-on-year [3]. - The third quarter alone saw a revenue of 1.401 billion yuan, down 15.02% year-on-year, and a net profit of -151 million yuan, a staggering decline of 153.64% [3]. Market Position - Bluefan Medical's total market capitalization is 5.64 billion yuan, significantly lower than the industry average of 11.01 billion yuan, ranking 63rd out of 124 in the medical device sector [3]. - The company's net asset value stands at 9.707 billion yuan, which is above the industry average of 3.893 billion yuan, ranking 7th [3]. - The price-to-earnings ratio is -14.79, while the industry average is 60.46, indicating a negative earnings situation [3]. - The gross margin is 13.66%, significantly lower than the industry average of 51.22%, ranking 121st [3]. Capital Flow - On December 3, 2025, the net outflow of main funds was 3.1814 million yuan, accounting for 8.16% of the total turnover [1][2]. - Retail investors showed a net inflow of 5.2753 million yuan, representing 13.54% of the total turnover on the same day [1][2]. - Over the past five days, the trend shows a consistent outflow of main funds, with the highest outflow recorded on December 2 at 12.9393 million yuan [2].